Management of Post-COVID Dyspnea

Oxygen Therapy Decision

The British Thoracic Society recommends starting oxygen only when SpO2 falls below 92% in COVID-19 patients, with strong recommendation for oxygen when SpO2 <90% 3, 4, 5
The current saturation of 94% falls within the target range of 94-98% for patients without risk factors for hypercapnic respiratory failure 6, 7
Monitor closely for deterioration—if SpO2 drops to <92%, begin supplemental oxygen at 2-6 L/min via nasal cannulae, targeting SpO2 94-98% 6, 8

Administer nebulized salbutamol 2.5-5 mg OR ipratropium bromide 0.25-0.5 mg immediately for symptomatic relief of dyspnea 1, 2
Use air-driven nebulizer, not oxygen-driven, to avoid unnecessary oxygen exposure and potential complications 1, 2
If response is inadequate after initial dose, combine both agents (salbutamol plus ipratropium) in the same nebulizer 1
Nebulization should take approximately 10 minutes for bronchodilators 2
Repeat dosing can be given at 4-6 hourly intervals, but may be used more frequently if required 1

Continue the current prednisone 20 mg daily—the patient is already on systemic corticosteroids which is appropriate for post-COVID management 1, 2
The typical course for acute exacerbations is prednisolone 30 mg/day for 7-14 days, so the current 20 mg dose is reasonable 1

Position the patient upright (sitting in a chair if possible) to optimize ventilation and reduce work of breathing 9, 7
Provide a hand-held fan directed at the face, as this is recommended by the British Thoracic Society as first-line treatment for breathlessness when oxygen saturation is normal 7
Offer reassurance, as anxiety naturally accompanies breathlessness and can worsen the sensation 9

Measure respiratory rate immediately—a rate >30 breaths/min requires urgent escalation even with adequate SpO2 6, 8
Monitor vital signs including heart rate, blood pressure, and mental status at least twice daily 8
Reassess oxygen saturation every 1-2 hours initially, then at least twice daily once stable 8
Consider arterial blood gas if clinical condition appears worse than SpO2 suggests, or if there is concern for hypercapnia 7

Respiratory rate >30 breaths/min indicates respiratory distress requiring immediate intervention 6, 8
SpO2 dropping below 92% mandates initiation of supplemental oxygen 3, 4, 5
SpO2 <85% requires high-flow oxygen at 15 L/min via reservoir mask 6, 8
Worsening mental status, inability to speak in full sentences, or signs of respiratory exhaustion warrant urgent medical evaluation 6

If nebulizers are truly unavailable, consider low-dose opioids (morphine 2-4 mg IV) for relief of breathlessness, though this is typically reserved for palliative settings 9, 7
Positioning and fan therapy become even more critical in resource-limited settings 7

Do not use oxygen-driven nebulizers in this patient—air-driven systems prevent unnecessary oxygen exposure 1, 2
Do not withhold bronchodilators based on absence of asthma/COPD history—post-COVID patients can have bronchospasm and airway inflammation that responds to bronchodilators 1
Do not rely solely on SpO2—respiratory rate and work of breathing are crucial parameters that may indicate deterioration before oxygen saturation falls 6, 8